4 juni 2025 Sweden
SwedenBio: Strategic business expansion: Growing your business in the US
SwedenBIO’s Working Group for Business Strategy, in collaboration with EY, hosted a seminar focused on how Swedish life science companies can successfully navigate entry into the U.S. market.
Ulf Hannelius, President and CEO of Diamyd Medical, contributed with perspectives on the company’s experience engaging with the FDA and navigating the regulatory landscape surrounding their application processes.
The seminar was recorded on Monday, June 2, 2025.
Read the article on the seminar
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.